Zota Health Care to Acquire 80% Stake in Globotask IT Consultancy for ₹25 Lakhs
Zota Health Care Limited will acquire an 80% stake in Globotask IT Consultancy Services Private Limited for ₹25 Lakhs. This move aims to enhance IT solutions for the company and its subsidiaries. The trading window will be closed from June 19, 2026, until 48 hours post-acquisition announcement.
The acquisition is for a relatively small amount (₹25 Lakhs) and involves a subsidiary focused on IT solutions, suggesting a moderate impact on the overall business operations and financial performance of Zota Health Care Limited.
The acquisition of a significant stake in an IT consultancy firm is a positive step for Zota Health Care Limited, likely to enhance its technological capabilities and operational efficiency.
Zota Health Care Limited has entered into a Memorandum of Understanding (MOU) to acquire an 80% stake in M/s Globotask IT Consultancy Services Private Limited (GITCL). The acquisition involves purchasing 8,000 equity shares of GITCL for an aggregate consideration of ₹25,00,000 (Rupees Twenty-Five Lakhs Only).
This acquisition is intended to enable GITCL to provide IT solutions, including cloud-based software development, Android/iOS application development, website development, and customized ERP software, to Zota Health Care Limited and its subsidiaries. The parties involved in the MOU are Zota Health Care Limited, GITCL, and its existing Promoters, Directors, and Shareholders: Mr. Digbijoy Sharma, Mr. Subhro Das, and Mr. Rohit P Das. The transaction does not fall within related party transactions as the promoters, promoter group, or group companies of Zota Health Care Limited have no interest in GITCL.
In connection with this announcement, the trading window for Zota Health Care Limited will remain closed from June 19, 2026, until 48 hours after the announcement of the said acquisition.
What to do with a filing like this
Zota Health Care LImited filed this with the NSE as a statutory disclosure, categorised under acquisition. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Zota Health Care LImited. Read the original for the full detail.